Literature DB >> 9914389

Role of PKC in the effects of alpha1-adrenergic stimulation on Ca2+ transients, contraction and Ca2+ current in guinea-pig ventricular myocytes.

S H Woo1, C O Lee.   

Abstract

The effects of alpha1-adrenoceptor stimulation on intracellular Ca2+ transients, contractility and L-type Ca2+ current (ICa,L) were studied in single cells isolated from ventricles of guinea-pig hearts. The aim of our study was to elucidate the mechanisms of the positive inotropic effect of alpha1-adrenergic stimulation by focussing on the role of protein kinase C (PKC). Phenylephrine, an alpha1-adrenergic agonist, at concentrations of 50-100 microM elicited a biphasic inotropic response: a transient negative inotropic response (22.9+/-6.0% of control) followed by a sustained positive inotropic response (61.0+/-8.4%, mean+/-SE, n=12). The Ca2+ transient decreased by 10.2+/-3.9% during the negative inotropic phase, while it increased by 67.7+/-10% (n=12) during the positive inotropic phase. These effects were inhibited by prazosin (1 microM), a alpha1-adrenergic antagonist. Phenylephrine increased the ICa,L by 60.8+/-21% (n=5) during the positive inotropic phase. To determine whether activation of PKC is responsible for the increases in Ca2+ transients, contractile amplitude and ICa,L during alpha1-adrenoceptor stimulation, we tested the effects of 4beta-phorbol 12-myristate 13-acetate (PMA), a PKC activator, and of bisindolylmaleimide I (GF109203X) and staurosporine, both of which are PKC inhibitors. PMA mimicked phenylephrine's effects on Ca2+ transients, contractile amplitude and ICa,L. PMA (100 nM) increased the Ca2+ transient, contractile amplitude and ICa,L by 131+/-17%, 137+/-25% (n=8), and 81.1+/-26% (n=5), respectively. Prior exposure to GF109203X (1 microM) or staurosporine (10 nM) prevented the phenylephrine-induced increases in Ca2+ transients, contractile amplitude and ICa,L. Our study suggests that during alpha1-adrenoceptor stimulation increase in ICa,L via PKC causes an increase in Ca2+ transients and thereby in the contractile force of the ventricular myocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9914389     DOI: 10.1007/s004240050787

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  9 in total

1.  Xestospongin C, a selective and membrane-permeable inhibitor of IP(3) receptor, attenuates the positive inotropic effect of alpha-adrenergic stimulation in guinea-pig papillary muscle.

Authors:  S Miyamoto; M Izumi; M Hori; M Kobayashi; H Ozaki; H Karaki
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

2.  K(ATP) channel gain-of-function leads to increased myocardial L-type Ca(2+) current and contractility in Cantu syndrome.

Authors:  Mark D Levin; Gautam K Singh; Hai Xia Zhang; Keita Uchida; Beth A Kozel; Phyllis K Stein; Atilla Kovacs; Ruth E Westenbroek; William A Catterall; Dorothy Katherine Grange; Colin G Nichols
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

3.  Phenylephrine acts via IP3-dependent intracellular NO release to stimulate L-type Ca2+ current in cat atrial myocytes.

Authors:  Y G Wang; E N Dedkova; X Ji; L A Blatter; S L Lipsius
Journal:  J Physiol       Date:  2005-06-09       Impact factor: 5.182

4.  Inhibition of cardiac L-type calcium channels by protein kinase C phosphorylation of two sites in the N-terminal domain.

Authors:  D McHugh; E M Sharp; T Scheuer; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

5.  Optogenetic toolkit reveals the role of Ca2+ sparklets in coordinated cell migration.

Authors:  Jin Man Kim; Minji Lee; Nury Kim; Won Do Heo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-17       Impact factor: 11.205

Review 6.  Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance.

Authors:  Timothy D O'Connell; Brian C Jensen; Anthony J Baker; Paul C Simpson
Journal:  Pharmacol Rev       Date:  2013-12-24       Impact factor: 25.468

Review 7.  Adrenergic signaling in heart failure: a balance of toxic and protective effects.

Authors:  Anthony J Baker
Journal:  Pflugers Arch       Date:  2014-03-14       Impact factor: 3.657

Review 8.  Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.

Authors:  Dianne M Perez
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

9.  Shift toward greater pathologic post-myocardial infarction remodeling with loss of the adaptive hypertrophic signaling of alpha1 adrenergic receptors in mice.

Authors:  Che-Chung Yeh; Yanying Fan; Yanchun Xu; Yi-Lin Yang; Paul C Simpson; Michael J Mann
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.